Drug Type Drug conjugates |
Synonyms- |
Target |
Mechanism M6PR inhibitors(mannose-6-phosphate receptor, cation dependent inhibitors), TNF-α modulators(Tumor necrosis factor α modulators), VEGF modulators(Vascular endothelial growth factor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | FR | 12 Mar 2024 | |
Inflammation | Preclinical | FR | 12 Mar 2024 |